{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:06:47Z","timestamp":1787317607629,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (INSERM), France"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070669"],"award-info":[{"award-number":["82070669"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Lipoprotein lipase (LPL) is the rate-limiting enzyme for triglyceride hydrolysis. Homozygous or compound heterozygous\n                      <jats:italic>LPL<\/jats:italic>\n                      variants cause autosomal recessive familial chylomicronemia syndrome (FCS), whereas simple heterozygous\n                      <jats:italic>LPL<\/jats:italic>\n                      variants are associated with hypertriglyceridemia (HTG) and HTG-related disorders.\n                      <jats:italic>LPL<\/jats:italic>\n                      frameshift coding sequence variants usually cause complete functional loss of the affected allele, thereby allowing exploration of the impact of different levels of LPL function in human disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All exons and flanking intronic regions of\n                      <jats:italic>LPL<\/jats:italic>\n                      were Sanger sequenced in patients with HTG-related acute pancreatitis (HTG-AP) or HTG-AP in pregnancy. Previously reported\n                      <jats:italic>LPL<\/jats:italic>\n                      frameshift coding sequence variants were collated from the Human Gene Mutation Database and through PubMed keyword searching. Original reports were manually evaluated for the following information: zygosity status of the variant, plasma LPL activity of the variant carrier, disease referred for genetic analysis, patient\u2019s age at genetic analysis, and patient\u2019s disease history. SpliceAI was employed to predict the potential impact of collated variants on splicing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two novel rare variants were identified, and 53 known\n                      <jats:italic>LPL<\/jats:italic>\n                      frameshift coding sequence variants were collated. Of the 51 variants informative for zygosity, 30 were simple heterozygotes, 12 were homozygotes, and 9 were compound heterozygotes. Careful evaluation of the 55 variants with respect to their clinical and genetic data generated several interesting findings. First, we conclude that 6\u20137% residual LPL function could significantly delay the age of onset of FCS and reduce the prevalence of FCS-associated syndromes. Second, whereas a large majority of\n                      <jats:italic>LPL<\/jats:italic>\n                      frameshift coding sequence variants completely disrupt gene function through their \"frameshift\" nature, a small fraction of these variants may act wholly or partly as \"in-frame\" variants, leading to the generation of protein products with some residual LPL function. Third, we identified two candidate\n                      <jats:italic>LPL<\/jats:italic>\n                      frameshift coding sequence variants that may retain residual function based on genotype\u2013phenotype correlation or SpliceAI-predicted data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This study reported two novel\n                      <jats:italic>LPL<\/jats:italic>\n                      variants and yielded new insights into the genotype\u2013phenotype relationship as it pertains to\n                      <jats:italic>LPL<\/jats:italic>\n                      frameshift coding sequence variants.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-023-01898-w","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:02:12Z","timestamp":1691766132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Frameshift coding sequence variants in the LPL gene: identification of two novel events and exploration of the genotype\u2013phenotype relationship for variants reported to date"],"prefix":"10.1186","volume":"22","author":[{"given":"Guofu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuepeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"1898_CR1","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1126\/science.3823907","volume":"235","author":"KL Wion","year":"1987","unstructured":"Wion KL, Kirchgessner TG, Lusis AJ, Schotz MC, Lawn RM. Human lipoprotein lipase complementary DNA sequence. Science. 1987;235:1638\u201341.","journal-title":"Science"},{"key":"1898_CR2","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1021\/bi00436a001","volume":"28","author":"SS Deeb","year":"1989","unstructured":"Deeb SS, Peng RL. Structure of the human lipoprotein lipase gene. Biochemistry. 1989;28:4131\u20135.","journal-title":"Biochemistry"},{"key":"1898_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbalip.2014.03.013","volume":"1841","author":"S Kersten","year":"2014","unstructured":"Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 2014;1841:919\u201333.","journal-title":"Biochim Biophys Acta"},{"key":"1898_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2019.05.023","volume":"30","author":"SG Young","year":"2019","unstructured":"Young SG, Fong LG, Beigneux AP, Allan CM, He C, Jiang H, Nakajima K, Meiyappan M, Birrane G, Ploug M. GPIHBP1 and lipoprotein lipase, partners in plasma triglyceride metabolism. Cell Metab. 2019;30:51\u201365.","journal-title":"Cell Metab"},{"key":"1898_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/joim.13016","volume":"287","author":"A Baass","year":"2020","unstructured":"Baass A, Paquette M, Bernard S, Hegele RA. Familial chylomicronemia syndrome: an under-recognized cause of severe hypertriglyceridaemia. J Intern Med. 2020;287:340\u20138.","journal-title":"J Intern Med"},{"key":"1898_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1161\/01.CIR.96.6.1737","volume":"96","author":"BG Nordestgaard","year":"1997","unstructured":"Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation. 1997;96:1737\u201344.","journal-title":"Circulation"},{"key":"1898_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jacl.2022.11.007","volume":"17","author":"SD Perera","year":"2023","unstructured":"Perera SD, Wang J, McIntyre AD, Dron JS, Hegele RA. The longitudinal triglyceride phenotype in heterozygotes with LPL pathogenic variants. J Clin Lipidol. 2023;17:87\u201393.","journal-title":"J Clin Lipidol"},{"key":"1898_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","volume":"41","author":"U Laufs","year":"2020","unstructured":"Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41:99\u2013109c.","journal-title":"Eur Heart J"},{"key":"1898_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/MPA.0000000000001637","volume":"49","author":"W Pu","year":"2020","unstructured":"Pu W, Luo G, Chen T, Jing L, Hu Q, Li X, Xia H, Deng M, Lu M, Chen X. A 5-year retrospective cohort study: epidemiology, etiology, severity, and outcomes of acute pancreatitis. Pancreas. 2020;49:1161\u20137.","journal-title":"Pancreas"},{"key":"1898_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12876-018-0821-z","volume":"18","author":"X Li","year":"2018","unstructured":"Li X, Ke L, Dong J, Ye B, Meng L, Mao W, Yang Q, Li W, Li J. Significantly different clinical features between hypertriglyceridemia and biliary acute pancreatitis: a retrospective study of 730 patients from a tertiary center. BMC Gastroenterol. 2018;18:89.","journal-title":"BMC Gastroenterol"},{"issue":"947\u2013953","key":"1898_CR11","first-page":"e941","volume":"13","author":"M Jin","year":"2019","unstructured":"Jin M, Bai X, Chen X, Zhang H, Lu B, Li Y, Lai Y, Qian J, Yang H. A 16-year trend of etiology in acute pancreatitis: The increasing proportion of hypertriglyceridemia-associated acute pancreatitis and its adverse effect on prognosis. J Clin Lipidol. 2019;13(947\u2013953):e941.","journal-title":"J Clin Lipidol"},{"key":"1898_CR12","doi-asserted-by":"publisher","first-page":"640859","DOI":"10.3389\/fgene.2021.640859","volume":"12","author":"Q Yang","year":"2021","unstructured":"Yang Q, Pu N, Li XY, Shi XL, Chen WW, Zhang GF, Hu YP, Zhou J, Chen FX, Li BQ, et al. Digenic inheritance and gene-environment interaction in a patient with hypertriglyceridemia and acute pancreatitis. Front Genet. 2021;12:640859.","journal-title":"Front Genet"},{"key":"1898_CR13","doi-asserted-by":"crossref","unstructured":"Pu N, Yang Q, Shi XL, Chen WW, Li XY, Zhang GF, Li G, Li BQ, Ke L, Tong ZH, et al. Gene-environment interaction between APOA5 c.553G>T and pregnancy in hypertriglyceridemia-induced acute pancreatitis. J Clin Lipidol. 2020;14:498\u2013506.","DOI":"10.1016\/j.jacl.2020.05.003"},{"key":"1898_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12944-019-1012-9","volume":"18","author":"WW Chen","year":"2019","unstructured":"Chen WW, Yang Q, Li XY, Shi XL, Pu N, Lu GT, Tong ZH, Chen JM, Li WQ. Identification of a novel and heterozygous LMF1 nonsense mutation in an acute pancreatitis patient with severe hypertriglyceridemia, severe obesity and heavy smoking. Lipids Health Dis. 2019;18:68.","journal-title":"Lipids Health Dis"},{"key":"1898_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12944-020-01249-z","volume":"19","author":"XY Li","year":"2020","unstructured":"Li XY, Pu N, Chen WW, Shi XL, Zhang GF, Ke L, Ye B, Tong ZH, Wang YH, Liu G, et al. Identification of a novel LPL nonsense variant and further insights into the complex etiology and expression of hypertriglyceridemia-induced acute pancreatitis. Lipids Health Dis. 2020;19:63.","journal-title":"Lipids Health Dis"},{"key":"1898_CR16","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, Hayden M, Heywood S, Millar DS, Phillips AD, Cooper DN. The Human Gene Mutation Database (HGMD\u00ae): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139:1197\u2013207.","journal-title":"Hum Genet"},{"key":"1898_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, Kosmicki JA, Arbelaez J, Cui W, Schwartz GB, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535\u201348.","journal-title":"Cell"},{"key":"1898_CR18","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/humu.22981","volume":"37","author":"JT den Dunnen","year":"2016","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux AF, Smith T, Antonarakis SE, Taschner PE. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat. 2016;37:564\u20139.","journal-title":"Hum Mutat"},{"key":"1898_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btab051","volume":"37","author":"M Lefter","year":"2021","unstructured":"Lefter M, Vis JK, Vermaat M, den Dunnen JT, Taschner PEM, Laros JFJ. Mutalyzer 2: next generation HGVS nomenclature checker. Bioinformatics. 2021;37:2811\u20137.","journal-title":"Bioinformatics"},{"key":"1898_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jacl.2017.01.013","volume":"11","author":"AD Laurie","year":"2017","unstructured":"Laurie AD, Kyle CV. A novel frameshift mutation in the lipoprotein lipase gene is rescued by alternative messenger RNA splicing. J Clin Lipidol. 2017;11:357\u201361.","journal-title":"J Clin Lipidol"},{"key":"1898_CR21","doi-asserted-by":"crossref","unstructured":"Lin JH, Tang XY, Boulling A, Zou WB, Masson E, Fichou Y, Raud L, Le Tertre M, Deng SJ, Berlivet I, et al. First estimate of the scale of canonical 5\u2019 splice site GT>GC variants capable of generating wild-type transcripts. Hum Mutat. 2019;40:1856\u201373.","DOI":"10.1002\/humu.23821"},{"key":"1898_CR22","doi-asserted-by":"publisher","first-page":"7913","DOI":"10.1093\/nar\/gky372","volume":"46","author":"R Leman","year":"2018","unstructured":"Leman R, Gaildrat P, Le Gac G, Ka C, Fichou Y, Audrezet MP, Caux-Moncoutier V, Caputo SM, Boutry-Kryza N, Leone M, et al. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico\/in vitro studies: an international collaborative effort. Nucleic Acids Res. 2018;46:7913\u201323.","journal-title":"Nucleic Acids Res"},{"key":"1898_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ebiom.2018.11.001","volume":"38","author":"JL Jin","year":"2018","unstructured":"Jin JL, Sun D, Cao YX, Zhang HW, Guo YL, Wu NQ, Zhu CG, Gao Y, Dong QT, Liu G, et al. Intensive genetic analysis for Chinese patients with very high triglyceride levels: Relations of mutations to triglyceride levels and acute pancreatitis. EBioMedicine. 2018;38:171\u20137.","journal-title":"EBioMedicine"},{"key":"1898_CR24","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1161\/ATVBAHA.107.150680","volume":"27","author":"J Wang","year":"2007","unstructured":"Wang J, Cao H, Ban MR, Kennedy BA, Zhu S, Anand S, Yusuf S, Pollex RL, Hegele RA. Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650). Arterioscler Thromb Vasc Biol. 2007;27:2450\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1898_CR25","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1073\/pnas.1909378117","volume":"117","author":"YC Hou","year":"2020","unstructured":"Hou YC, Yu HC, Martin R, Cirulli ET, Schenker-Ahmed NM, Hicks M, Cohen IV, Jonsson TJ, Heister R, Napier L, et al. Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging. Proc Natl Acad Sci U S A. 2020;117:3053\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1898_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0004563213477393","volume":"50","author":"M Overgaard","year":"2013","unstructured":"Overgaard M, Brasen CL, Svaneby D, Feddersen S, Nybo M. Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene. Ann Clin Biochem. 2013;50:374\u20139.","journal-title":"Ann Clin Biochem"},{"key":"1898_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0014-5793(95)00582-T","volume":"367","author":"R Busca","year":"1995","unstructured":"Busca R, Peinado J, Vilella E, Auwerx J, Deeb SS, Vilaro S, Reina M. The mutant Asn291\u2013>Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett. 1995;367:257\u201362.","journal-title":"FEBS Lett"},{"key":"1898_CR28","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0022-2275(20)41340-9","volume":"33","author":"M Reina","year":"1992","unstructured":"Reina M, Brunzell JD, Deeb SS. Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J Lipid Res. 1992;33:1823\u201332.","journal-title":"J Lipid Res"},{"key":"1898_CR29","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1016\/S0021-9258(19)39449-9","volume":"265","author":"M Emi","year":"1990","unstructured":"Emi M, Wilson DE, Iverius PH, Wu L, Hata A, Hegele R, Williams RR, Lalouel JM. Missense mutation (Gly\u2013\u2013Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem. 1990;265:5910\u20136.","journal-title":"J Biol Chem"},{"key":"1898_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0022-2275(20)30146-2","volume":"43","author":"J Peterson","year":"2002","unstructured":"Peterson J, Ayyobi AF, Ma Y, Henderson H, Reina M, Deeb SS, Santamarina-Fojo S, Hayden MR, Brunzell JD. Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene. J Lipid Res. 2002;43:398\u2013406.","journal-title":"J Lipid Res"},{"key":"1898_CR31","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.atherosclerosis.2010.11.026","volume":"214","author":"D Evans","year":"2011","unstructured":"Evans D, Arzer J, Aberle J, Beil FU. Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia. Atherosclerosis. 2011;214:386\u201390.","journal-title":"Atherosclerosis"},{"key":"1898_CR32","first-page":"431","volume":"59","author":"P Benlian","year":"1996","unstructured":"Benlian P, Foubert L, Gagne E, Bernard L, De Gennes JL, Langlois S, Robinson W, Hayden M. Complete paternal isodisomy for chromosome 8 unmasked by lipoprotein lipase deficiency. Am J Hum Genet. 1996;59:431\u20136.","journal-title":"Am J Hum Genet"},{"key":"1898_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1139\/Y09-005","volume":"87","author":"AR Rahalkar","year":"2009","unstructured":"Rahalkar AR, Giffen F, Har B, Ho J, Morrison KM, Hill J, Wang J, Hegele RA, Joy T. Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review. Can J Physiol Pharmacol. 2009;87:151\u201360.","journal-title":"Can J Physiol Pharmacol"},{"key":"1898_CR34","doi-asserted-by":"crossref","unstructured":"Foubert L, De Gennes JL, Benlian P, Truffert J, Miao L, Hayden MR. Compound heterozygosity for frameshift mutations in the gene for lipoprotein lipase in a patient with early-onset chylomicronemia. Hum Mutat. 1998;(1):141\u20134.","DOI":"10.1002\/humu.1380110148"},{"key":"1898_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2015.04.815","volume":"241","author":"C Rabacchi","year":"2015","unstructured":"Rabacchi C, Pisciotta L, Cefalu AB, Noto D, Fresa R, Tarugi P, Averna M, Bertolini S, Calandra S. Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia. Atherosclerosis. 2015;241:79\u201386.","journal-title":"Atherosclerosis"},{"key":"1898_CR36","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJM199609193351203","volume":"335","author":"P Benlian","year":"1996","unstructured":"Benlian P, De Gennes JL, Foubert L, Zhang H, Gagne SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med. 1996;335:848\u201354.","journal-title":"N Engl J Med"},{"issue":"1482\u20131492","key":"1898_CR37","volume":"12","author":"MJ Ariza","year":"2018","unstructured":"Ariza MJ, Rioja J, Ibarretxe D, Camacho A, Diaz-Diaz JL, Mangas A, Carbayo-Herencia JA, Ruiz-Ocana P, Lamiquiz-Moneo I, Mosquera D, et al. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society. J Clin Lipidol. 2018;12(1482\u20131492): e1483.","journal-title":"J Clin Lipidol"},{"key":"1898_CR38","doi-asserted-by":"publisher","first-page":"145310","DOI":"10.1016\/j.gene.2020.145310","volume":"768","author":"X Hu","year":"2021","unstructured":"Hu X, Chen L, Gong C, Guo J, Chen Y, Wang Q, Guo R, Li W, Hao C. Whole exome sequencing for non-selective pediatric patients with hyperlipidemia. Gene. 2021;768:145310.","journal-title":"Gene"},{"key":"1898_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cca.2013.11.025","volume":"429","author":"JM Martin-Campos","year":"2014","unstructured":"Martin-Campos JM, Julve J, Roig R, Martinez S, Errico TL, Martinez-Couselo S, Escola-Gil JC, Mendez-Gonzalez J, Blanco-Vaca F. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency. Clin Chim Acta. 2014;429:61\u20138.","journal-title":"Clin Chim Acta"},{"key":"1898_CR40","first-page":"511","volume":"7","author":"HE Henderson","year":"1990","unstructured":"Henderson HE, Devlin R, Peterson J, Brunzell JD, Hayden MR. Frameshift mutation in exon 3 of the lipoprotein lipase gene causes a premature stop codon and lipoprotein lipase deficiency. Mol Biol Med. 1990;7:511\u20137.","journal-title":"Mol Biol Med"},{"key":"1898_CR41","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cge.13250","volume":"94","author":"O Marmontel","year":"2018","unstructured":"Marmontel O, Charriere S, Simonet T, Bonnet V, Dumont S, Mahl M, Jacobs C, Nony S, Chabane K, Bozon D, et al. Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy. Clin Genet. 2018;94:132\u201340.","journal-title":"Clin Genet"},{"key":"1898_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.671536","volume":"9","author":"F Wang","year":"2021","unstructured":"Wang F, Wang F, Zhou X, Yi Y, Zhao J. A novel lipoprotein lipase mutation in an infant with glycogen storage disease type-Ib and severe hypertriglyceridemia. Front Pediatr. 2021;9: 671536.","journal-title":"Front Pediatr"},{"key":"1898_CR43","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1210\/jc.2005-0205","volume":"90","author":"V Pruneta-Deloche","year":"2005","unstructured":"Pruneta-Deloche V, Marcais C, Perrot L, Sassolas A, Delay M, Estour B, Lagarde M, Moulin P. Combination of circulating antilipoprotein lipase (Anti-LPL) antibody and heterozygous S172 fsX179 mutation of LPL gene leading to chronic hyperchylomicronemia. J Clin Endocrinol Metab. 2005;90:3995\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1898_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096482","volume":"9","author":"M Di Filippo","year":"2014","unstructured":"Di Filippo M, Marcais C, Charriere S, Marmontel O, Broyer M, Delay M, Merlin M, Nollace A, Valero R, Lagarde M, et al. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects. PLoS ONE. 2014;9: e96482.","journal-title":"PLoS ONE"},{"key":"1898_CR45","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/cge.13832","volume":"98","author":"O Marmontel","year":"2020","unstructured":"Marmontel O, Rollat-Farnier PA, Wozny AS, Charriere S, Vanhoye X, Simonet T, Chatron N, Collin-Chavagnac D, Nony S, Dumont S, et al. Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia. Clin Genet. 2020;98:589\u201394.","journal-title":"Clin Genet"},{"key":"1898_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0163-7258(96)00005-8","volume":"70","author":"V Murthy","year":"1996","unstructured":"Murthy V, Julien P, Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther. 1996;70:101\u201335.","journal-title":"Pharmacol Ther"},{"key":"1898_CR47","doi-asserted-by":"crossref","unstructured":"Takagi A, Ikeda Y, Tsutsumi Z, Shoji T, Yamamoto A. Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript. J Clin Invest. 1992;89:581\u201391.","DOI":"10.1172\/JCI115624"},{"key":"1898_CR48","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jacl.2016.02.015","volume":"10","author":"P Pingitore","year":"2016","unstructured":"Pingitore P, Lepore SM, Pirazzi C, Mancina RM, Motta BM, Valenti L, Berge KE, Retterstol K, Leren TP, Wiklund O, Romeo S. Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia. J Clin Lipidol. 2016;10:816\u201323.","journal-title":"J Clin Lipidol"},{"key":"1898_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","volume":"272","author":"RP Surendran","year":"2012","unstructured":"Surendran RP, Visser ME, Heemelaar S, Wang J, Peter J, Defesche JC, Kuivenhoven JA, Hosseini M, Peterfy M, Kastelein JJ, et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med. 2012;272:185\u201396.","journal-title":"J Intern Med"},{"key":"1898_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-8981(99)00060-1","volume":"285","author":"J Kobayashi","year":"1999","unstructured":"Kobayashi J, Nagashima I, Taira K, Hikita M, Tamura K, Bujo H, Morisaki N, Saito Y. A novel frameshift mutation in exon 6 (the site of Asn 291) of the lipoprotein lipase gene in type I hyperlipidemia. Clin Chim Acta. 1999;285:173\u201382.","journal-title":"Clin Chim Acta"},{"key":"1898_CR51","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1172\/JCI115229","volume":"87","author":"HE Henderson","year":"1991","unstructured":"Henderson HE, Ma Y, Hassan MF, Monsalve MV, Marais AD, Winkler F, Gubernator K, Peterson J, Brunzell JD, Hayden MR. Amino acid substitution (Ile194----Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin. J Clin Invest. 1991;87:2005\u201311.","journal-title":"J Clin Invest."},{"key":"1898_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0021-9258(18)52459-5","volume":"266","author":"HL Dichek","year":"1991","unstructured":"Dichek HL, Fojo SS, Beg OU, Skarlatos SI, Brunzell JD, Cutler GB Jr, Brewer HB Jr. Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome. J Biol Chem. 1991;266:473\u20137.","journal-title":"J Biol Chem"},{"key":"1898_CR53","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1194\/jlr.M600382-JLR200","volume":"48","author":"Y Hu","year":"2007","unstructured":"Hu Y, Ren Y, Luo RZ, Mao X, Li X, Cao X, Guan L, Chen X, Li J, Long Y, et al. Novel mutations of the lipoprotein lipase gene associated with hypertriglyceridemia in members of type 2 diabetic pedigrees. J Lipid Res. 2007;48:1681\u20138.","journal-title":"J Lipid Res"},{"key":"1898_CR54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s10545-006-0310-3","volume":"29","author":"MC Nierman","year":"2006","unstructured":"Nierman MC, Peter J, Khoo KL, Defesche JC. Lipoprotein lipase gene analyses in one Turkish family and three different Chinese families with severe hypertriglyceridaemia: one novel and several established mutations. J Inherit Metab Dis. 2006;29:686.","journal-title":"J Inherit Metab Dis"},{"key":"1898_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41525-020-00150-z","volume":"5","author":"H Cheema","year":"2020","unstructured":"Cheema H, Bertoli-Avella AM, Skrahina V, Anjum MN, Waheed N, Saeed A, Beetz C, Perez-Lopez J, Rocha ME, Alawbathani S, et al. Genomic testing in 1019 individuals from 349 Pakistani families results in high diagnostic yield and clinical utility. NPJ Genom Med. 2020;5:44.","journal-title":"NPJ Genom Med"},{"key":"1898_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12098-020-03305-z","volume":"88","author":"S Kuthiroly","year":"2021","unstructured":"Kuthiroly S, Yesodharan D, Radhakrishnan N, Ganapathy A, Mannan AU, Hoffmann MM, Nampoothiri S. Lipoprotein lipase deficiency. Indian J Pediatr. 2021;88:147\u201353.","journal-title":"Indian J Pediatr"},{"key":"1898_CR57","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jacl.2015.12.015","volume":"10","author":"R Rodrigues","year":"2016","unstructured":"Rodrigues R, Artieda M, Tejedor D, Martinez A, Konstantinova P, Petry H, Meyer C, Corzo D, Sundgreen C, Klor HU, et al. Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency. J Clin Lipidol. 2016;10:394\u2013409.","journal-title":"J Clin Lipidol"},{"key":"1898_CR58","doi-asserted-by":"crossref","unstructured":"Dron JS, Wang J, McIntyre AD, Iacocca MA, Robinson JF, Ban MR, Cao H, Hegele RA. Six years\u2019 experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias. BMC Med Genomics. 2020;13:23.","DOI":"10.1186\/s12920-020-0669-2"},{"key":"1898_CR59","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.ajhg.2018.04.003","volume":"102","author":"KS Raraigh","year":"2018","unstructured":"Raraigh KS, Han ST, Davis E, Evans TA, Pellicore MJ, McCague AF, Joynt AT, Lu Z, Atalar M, Sharma N, et al. Functional assays are essential for interpretation of missense variants associated with variable expressivity. Am J Hum Genet. 2018;102:1062\u201377.","journal-title":"Am J Hum Genet"},{"key":"1898_CR60","doi-asserted-by":"crossref","unstructured":"Masson E, Zou WB, Pu N, Rebours V, G\u00e9nin E, Wu H, Lin JH, Wang YC, Franco-Chinese GREPAN Study Group, Li ZS, et al. Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN Study Group. Pancreatology. 2023;23:491\u2013506.","DOI":"10.1016\/j.pan.2023.04.004"},{"key":"1898_CR61","doi-asserted-by":"crossref","unstructured":"Masson E, Berthet S, Le Rhun M, Ka C, Autret S, Gourlaouen I, French GREPAN Study Group, Cooper DN, F\u00e9rec C, et al. Identification of protease-sensitive but not misfolding PNLIP variants in familial and hereditary pancreatitis. Pancreatology. 2023;23:507\u201311.","DOI":"10.1016\/j.pan.2023.04.004"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01898-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01898-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01898-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:25:31Z","timestamp":1700389531000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01898-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1898"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01898-w","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Jinling Hospital (2021NZKY-042\u201301). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}